BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36967480)

  • 1. Immunotherapeutic approach to reduce senescent cells and alleviate senescence-associated secretory phenotype in mice.
    Shrestha N; Chaturvedi P; Zhu X; Dee MJ; George V; Janney C; Egan JO; Liu B; Foster M; Marsala L; Wong P; Cubitt CC; Foltz JA; Tran J; Schappe T; Hsiao K; Leclerc GM; You L; Echeverri C; Spanoudis C; Carvalho A; Kanakaraj L; Gilkes C; Encalada N; Kong L; Wang M; Fang B; Wang Z; Jiao JA; Muniz GJ; Jeng EK; Valdivieso N; Li L; Deth R; Berrien-Elliott MM; Fehniger TA; Rhode PR; Wong HC
    Aging Cell; 2023 May; 22(5):e13806. PubMed ID: 36967480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells.
    Chaturvedi P; George V; Shrestha N; Wang M; Dee MJ; Zhu X; Liu B; Egan J; D'Eramo F; Spanoudis C; Gallo V; Echeverri C; You L; Kong L; Fang B; Jeng EK; Rhode PR; Wong HC
    Mol Ther; 2022 Mar; 30(3):1171-1187. PubMed ID: 35051615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
    Murakami T; Inagaki N; Kondoh H
    Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging.
    Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X
    J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roxithromycin attenuates bleomycin-induced pulmonary fibrosis by targeting senescent cells.
    Zhang X; Dong Y; Li WC; Tang BX; Li J; Zang Y
    Acta Pharmacol Sin; 2021 Dec; 42(12):2058-2068. PubMed ID: 33654217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
    Malaquin N; Rodier F
    Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Samakkarnthai P; Saul D; Zhang L; Aversa Z; Doolittle ML; Sfeir JG; Kaur J; Atkinson EJ; Edwards JR; Russell GG; Pignolo RJ; Kirkland JL; Tchkonia T; Niedernhofer LJ; Monroe DG; Lebrasseur NK; Farr JN; Robbins PD; Khosla S
    Aging (Albany NY); 2023 May; 15(9):3331-3355. PubMed ID: 37154858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanotransduction of MLO-Y4 cells is disrupted by the senescence-associated secretory phenotype of neighboring cells.
    Gardinier JD; Chougule A; Zhang C
    J Cell Physiol; 2022 Apr; 237(4):2249-2257. PubMed ID: 35102547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy.
    Liu H; Xu Q; Wufuer H; Li Z; Sun R; Jiang Z; Dou X; Fu Q; Campisi J; Sun Y
    Aging Cell; 2024 Jan; 23(1):e13921. PubMed ID: 37475161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senotherapeutic-like effect of Silybum marianum flower extract revealed on human skin cells.
    Woo J; Shin S; Cho E; Ryu D; Garandeau D; Chajra H; Fréchet M; Park D; Jung E
    PLoS One; 2021; 16(12):e0260545. PubMed ID: 34914725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis signal-regulating kinase 1 promotes inflammation in senescence and aging.
    Odawara T; Yamauchi S; Ichijo H
    Commun Biol; 2024 Jun; 7(1):691. PubMed ID: 38839869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique Human and Mouse β-Cell Senescence-Associated Secretory Phenotype (SASP) Reveal Conserved Signaling Pathways and Heterogeneous Factors.
    Midha A; Pan H; Abarca C; Andle J; Carapeto P; Bonner-Weir S; Aguayo-Mazzucato C
    Diabetes; 2021 May; 70(5):1098-1116. PubMed ID: 33674410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescent Cells: Dual Implications on the Retinal Vascular System.
    Habibi-Kavashkohie MR; Scorza T; Oubaha M
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3.
    Tripathi U; Nchioua R; Prata LGPL; Zhu Y; Gerdes EOW; Giorgadze N; Pirtskhalava T; Parker E; Xue A; Espindola-Netto JM; Stenger S; Robbins PD; Niedernhofer LJ; Dickinson SL; Allison DB; Kirchhoff F; Sparrer KMJ; Tchkonia T; Kirkland JL
    Aging (Albany NY); 2021 Sep; 13(18):21838-21854. PubMed ID: 34531331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target.
    Narasimhan A; Flores RR; Camell CD; Bernlohr DA; Robbins PD; Niedernhofer LJ
    Curr Diab Rep; 2022 Nov; 22(11):537-548. PubMed ID: 36239841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disuse-induced muscle fibrosis, cellular senescence, and senescence-associated secretory phenotype in older adults are alleviated during re-ambulation with metformin pre-treatment.
    Petrocelli JJ; McKenzie AI; de Hart NMMP; Reidy PT; Mahmassani ZS; Keeble AR; Kaput KL; Wahl MP; Rondina MT; Marcus RL; Welt CK; Holland WL; Funai K; Fry CS; Drummond MJ
    Aging Cell; 2023 Nov; 22(11):e13936. PubMed ID: 37486024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ENPP5, a senescence-associated secretory phenotype factor, prevents skin aging.
    Takaya K; Kishi K
    Biogerontology; 2024 Jun; 25(3):529-542. PubMed ID: 38436793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of senescence-associated secretory phenotype by knockdown of secreted frizzled-related protein 4 contributes to the prevention of skin aging.
    Takaya K; Asou T; Kishi K
    Aging (Albany NY); 2022 Sep; 14(20):8167-8178. PubMed ID: 36084952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
    Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.